Osaic Holdings’s Serina Therapeutics SER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.94K Buy
1,001
+999
+49,950% +$2.2K ﹤0.01% 7058
2025
Q4
$2 Sell
2
-9
-82% -$36 ﹤0.01% 7807
2025
Q3
$54 Hold
11
﹤0.01% 7783
2025
Q2
$67 Buy
11
+1
+10% +$6 ﹤0.01% 7594
2025
Q1
$55 Buy
10
+5
+100% +$24 ﹤0.01% 7278
2024
Q4
$25 Sell
5
-5
-50% -$30 ﹤0.01% 7317
2024
Q3
$66 Sell
10
-1
-9% -$8 ﹤0.01% 7279
2024
Q2
$103 Buy
11
+4
+57% +$39 ﹤0.01% 7241
2024
Q1
$89 Sell
7
-85
-92% -$1.19K ﹤0.01% 7047
2023
Q4
$1.25K Sell
92
-4
-4% -$74 ﹤0.01% 6675
2023
Q3
$2.3K Buy
96
+4
+4% +$106 ﹤0.01% 6581
2023
Q2
$2.89K Sell
92
-1
-1% -$21 ﹤0.01% 6533
2023
Q1
$2.18K Hold
93
﹤0.01% 6676
2022
Q4
$2K Hold
93
﹤0.01% 6722
2022
Q3
$2K Hold
93
﹤0.01% 6855
2022
Q2
$2K Hold
93
﹤0.01% 6952
2022
Q1
$6K Sell
93
-1
-1% -$28 ﹤0.01% 6423
2021
Q4
$3K Hold
94
﹤0.01% 6923
2021
Q3
$3K Hold
94
﹤0.01% 6779
2021
Q2
$5K Hold
94
﹤0.01% 6391
2021
Q1
$5K Hold
94
﹤0.01% 6184
2020
Q4
$5K Sell
94
-3
-3% -$173 ﹤0.01% 5804
2020
Q3
$2K Buy
97
+3
+3% +$107 ﹤0.01% 5905
2020
Q2
$3K Hold
94
﹤0.01% 5706
2020
Q1
$3K Buy
+94
New +$4.42K ﹤0.01% 5590

Other funds holding SER

Osaic Holdings's SER Position: Q1 2026 in Review

Osaic Holdings increased its Serina Therapeutics (SER) stake by 49,950% in Q1 2026, buying an estimated $2.2K and bringing the position to 1,001 shares worth $1.94K. The position accounts for ﹤0.01% of the portfolio, ranked #7058.

Osaic Holdings first reported a position in SER in Q1 2020 and has held it in 25 quarters since. The position peaked at $6K in Q1 2022. 25 funds tracked by Wall St. Rank hold SER as of Q1 2026.

  • Osaic Holdings held 1,001 shares of Serina Therapeutics worth $1.94K as of Q1 2026.
  • Osaic Holdings bought 999 Serina Therapeutics shares in Q1 2026, an estimated $2.2K.
  • Serina Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7058 holding.
  • Osaic Holdings first reported a position in Serina Therapeutics in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Serina Therapeutics position peaked at $6K in Q1 2022.
  • 25 funds tracked by Wall St. Rank held Serina Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.